Drug development needs to look beyond clinical trials. Real World Physicians do not practice as they do in clinical trials, i.e. they do not follow guidelines. Real World Patients present complexities: co-morbidities, poly-pharmacy, environment/lifestyle. Significant weaknesses need to be considered.
Building a Platform for Modeling Risk and Opportunities in Drug Development
Molinaro Sabrina
2016
Abstract
Drug development needs to look beyond clinical trials. Real World Physicians do not practice as they do in clinical trials, i.e. they do not follow guidelines. Real World Patients present complexities: co-morbidities, poly-pharmacy, environment/lifestyle. Significant weaknesses need to be considered.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_353683-doc_114420.pdf
solo utenti autorizzati
Descrizione: Building a Platform for Modeling Risk and Opportunities in Drug Development
Tipologia:
Versione Editoriale (PDF)
Dimensione
2.27 MB
Formato
Adobe PDF
|
2.27 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
